|
| During the 1990’s, Michigan Vascular Center (MVC) surgeons traveled abroad to learn the new technique of carotid artery stenting. This was long before FDA approval of the devices, which could then only be used in patients in the context of a clinical trial. By 1998, the Michigan Vascular Research Center (MVRC) was created to first facilitate clinical trial participation, and then clinical trial creation. This was one of the very first research centers outside of a University setting. | | | MVRC employs specifically educated staff to manage and operate the department; screening new trials, enrolling in trials, matching patients with trials when appropriate, and ensuring compliance with all of the regulatory matters. By participating in a clinical trial a patient gains access to treatments or procedures not yet available in the community. In fact, MVRC has taken a leadership role in the State for bringing state-of-the-art endovascular treatments to Michigan: | | | - First in Michigan to implant a FDA approved carotid stent manufactured by Guidant, Inc. in September 2004.
| - First and only site in Michigan to implant a superficial femoral artery drug-coated stent manufactured by Cook, Inc. in October 2005.
| - First in Michigan to implant a FDA approved abdominal aortic aneurysm pressure monitoring device, manufactured by CardioMEMS in June 2006. This device is placed in the AAA sac at the time of endograft repair in order to remotely measure sac pressure over time.
| | | Since its formation in 1998, MVRC has participated in over 48 device, drug and investigator-initiated trials. Ten vascular surgeons, a nurse practitioner, a physician assistant, three clinical research coordinators and a research assistant comprise our team. Of the 20 research trials conducted at MVRC, 13 are currently open to enrollment. Because of MVRC’s dedication and commitment toward conducting research, we were the first in the state to enroll patients in several trials. | | | | Current trials are recruiting patients in the areas of carotid disease, aortic aneurysm disease, Inferior Vena Cava Filter, peripheral arterial disease, hemodialysis access, Iliac Artery Stenosis, Renal Artery Stenosis, Surgical Hemostasis and Vascular Profile Studies. A list of our active trials can be found here. | | | Without clinical research, medical and surgical innovations could not occur. Because our generation and generations to come rely on today’s clinical research efforts, MVRC is committed to offering innovative and otherwise unavailable treatments to our patients.
|
|
